Teacher Retirement System of Texas cut its stake in Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 10.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 39,189 shares of the company’s stock after selling 4,389 shares during the period. Teacher Retirement System of Texas owned 0.07% of Astrana Health worth $975,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also modified their holdings of the company. Vanguard Group Inc. increased its holdings in shares of Astrana Health by 4.5% in the first quarter. Vanguard Group Inc. now owns 4,898,992 shares of the company’s stock valued at $151,918,000 after purchasing an additional 213,033 shares in the last quarter. SteelPeak Wealth LLC lifted its holdings in Astrana Health by 4.8% during the 1st quarter. SteelPeak Wealth LLC now owns 568,176 shares of the company’s stock worth $17,619,000 after buying an additional 26,192 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its position in Astrana Health by 6.0% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 499,529 shares of the company’s stock valued at $15,490,000 after buying an additional 28,200 shares during the last quarter. Invesco Ltd. increased its stake in shares of Astrana Health by 13.0% in the 1st quarter. Invesco Ltd. now owns 292,043 shares of the company’s stock valued at $9,056,000 after buying an additional 33,523 shares during the period. Finally, Royce & Associates LP increased its stake in shares of Astrana Health by 13.8% in the 1st quarter. Royce & Associates LP now owns 290,707 shares of the company’s stock valued at $9,015,000 after buying an additional 35,155 shares during the period. 52.77% of the stock is owned by institutional investors.
Astrana Health Stock Performance
Shares of Astrana Health stock opened at $33.36 on Friday. The firm has a fifty day moving average of $30.57 and a two-hundred day moving average of $27.96. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.59 and a current ratio of 1.59. The stock has a market capitalization of $1.87 billion, a price-to-earnings ratio of 65.41, a PEG ratio of 0.90 and a beta of 0.80. Astrana Health, Inc. has a 52 week low of $21.20 and a 52 week high of $60.91.
Analysts Set New Price Targets
Several brokerages have recently issued reports on ASTH. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Astrana Health in a research note on Wednesday, October 8th. Zacks Research upgraded Astrana Health from a “strong sell” rating to a “hold” rating in a research report on Friday, October 10th. Four investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, Astrana Health presently has an average rating of “Moderate Buy” and a consensus price target of $47.40.
Read Our Latest Report on ASTH
About Astrana Health
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Featured Articles
- Five stocks we like better than Astrana Health
- Are Penny Stocks a Good Fit for Your Portfolio?
- CAVA Stock Looking for Direction After Earnings Miss
- How to Calculate Inflation Rate
- 3 Small AI Stocks Ready to Explode (All Under $20)
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- After 16% Fall, Analysts Eye a Big Recovery in Meta Platforms
Want to see what other hedge funds are holding ASTH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astrana Health, Inc. (NASDAQ:ASTH – Free Report).
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.
